VEOPOZ
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
61755-014 -
Package NDC
61755-014-01 -
Application number
BLA761339 -
SPL ID
a8be5cf0-49ba-4795-a2e5-7ea07f495958 -
SPL set ID
a8d6f10e-9430-450a-a3dd-b538f9b2a308 -
UNII
0JJ21K6L2I -
RxCUI
2663945 -
RxCUI
2663952
What the source publishes
- Labeler
- Regeneron Pharmaceuticals, Inc.
- Active ingredients
- Pozelimab
- Form
- INJECTION, SOLUTION
- Routes
- INTRAVENOUS, SUBCUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "VEOPOZ",
"splId": "a8be5cf0-49ba-4795-a2e5-7ea07f495958",
"labels": [
{
"setId": "a8d6f10e-9430-450a-a3dd-b538f9b2a308",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a8d6f10e-9430-450a-a3dd-b538f9b2a308",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a8d6f10e-9430-450a-a3dd-b538f9b2a308"
}
],
"routes": [
"INTRAVENOUS",
"SUBCUTANEOUS"
],
"labeler": "Regeneron Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL, SINGLE-DOSE in 1 CARTON (61755-014-01) / 2 mL in 1 VIAL, SINGLE-DOSE (61755-014-00)",
"package_ndc": "61755-014-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20230818"
}
],
"productId": "61755-014_a8be5cf0-49ba-4795-a2e5-7ea07f495958",
"useDomain": "unknown",
"dosageForm": "INJECTION, SOLUTION",
"productNdc": "61755-014",
"deaSchedule": null,
"genericName": "Pozelimab",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "POZELIMAB",
"strength": "200 mg/mL"
}
],
"applicationNumber": "BLA761339",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20230818",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175575",
"N0000175974"
],
"unii": [
"0JJ21K6L2I"
],
"rxcui": [
"2663945",
"2663952"
],
"spl_set_id": [
"a8d6f10e-9430-450a-a3dd-b538f9b2a308"
],
"pharm_class_epc": [
"Complement Inhibitor [EPC]"
],
"pharm_class_moa": [
"Complement Inhibitors [MoA]"
],
"manufacturer_name": [
"Regeneron Pharmaceuticals, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:61755-014_a8be5cf0-49ba-4795-a2e5-7ea07f495958"